Chemerin, a novel player in inflammatory bowel disease
Author:
- 7 April 2014
- journal article
- review article
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 11 (4) , 315-316
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The Chemerin/ChemR23 System Does Not Affect the Pro-Inflammatory Response of Mouse and Human Macrophages Ex VivoPLOS ONE, 2012
- “Metabolic Aspects” In Inflammatory Bowel DiseasesCurrent Drug Delivery, 2012
- Intestinal macrophages – specialised adaptation to a unique environmentEuropean Journal of Immunology, 2011
- Chemerin: at the crossroads of inflammation and obesityTrends in Endocrinology & Metabolism, 2010
- Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohnʼs diseaseInflammatory Bowel Diseases, 2010
- Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitisInflammatory Bowel Diseases, 2010
- Epithelial cells in fetal intestine produce chemerin to recruit macrophagesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- The genetics and immunopathogenesis of inflammatory bowel diseaseNature Reviews Immunology, 2008
- Chemokine-like receptor 1 expression by macrophages in vivo: Regulation by TGF-β and TLR ligandsExperimental Hematology, 2006
- Experimental models of inflammatory bowel diseaseGastroenterology, 1995